Novel biomarker-driven trial of a cell and gene therapy for the treatment of malignant pleural mesothelioma (MPM): the STRATEGIC trial. (January 2020) - Davies, A.; Sage, B.; Kolluri, K.; Graham, R.; Alrifai, D.; Weil, B.; Patrick, P.S.; Champion, K.; Day, A.; Popova, B.; Wheeler, G.; Fullen, D.; et al.